At a glance
ClinicalIndex Comparison RecordN/ACompleted· 194 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
PRESTIGE Observational Study
In Brief
An observational study for Degenerative Cervical Disc Disease. Completed, enrolled 194 participants across 26 sites in 8 countries.
Detailed Summary
Prestige artificial disc replacement is an alternative treatment option with 16 years of experience addressing the unmet needs of surgical fusion interventions. Previous studies on the PRESTIGE® cervical disc have proven the safety and effectiveness of artificial disc surgery with level I evidence. The PRESTIGE Observational Study is intended to collect prospectively observational data primarily on the Quality of Life (QoL).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDegenerative Cervical Disc Disease
CountriesCzechia, Greece, Hungary, Kuwait, Poland, Saudi Arabia, Serbia, Slovakia
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2008
First PostedApr 2009
Primary CompletionNov 2013
TodayJul 2026
First PostedApr 3, 2009
Enrollment StartApr 1, 2008
Primary CompletionNov 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 17.2 years ago